Literature DB >> 12038143

Safety studies of the oral rabies vaccine SAD B19 in striped skunk (Mephitis mephitis).

A Vos1, E Pommerening, L Neubert, S Kachel, A Neubert.   

Abstract

Safety of the modified live rabies virus vaccine, SAD B19, was studied in striped skunks (Mephitis mephitis). Seven skunks received 10(7.9) foci formatting units by direct oral administration. In four cages, a vaccinated animal was placed with a control animal, the other three vaccinated skunks were housed individually. Saliva and nasal swabs were collected 1, 2, 4, 24, 48, and 72 hr post-vaccination. From all vaccinated and control animals (n = 11) blood samples were collected 0, 28, 56, 84, and 296 days post-vaccination. Three of seven vaccinated skunks seroconverted. None of the control animals had detectable levels of rabies virus neutralizing antibodies. Also no vaccine virus was isolated from the nasal and saliva swabs collected from any animal. Thus, SAD B19 was innocuous for skunks in our study after direct oral administration at field concentration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12038143     DOI: 10.7589/0090-3558-38.2.428

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  10 in total

1.  Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses.

Authors:  Joseph E Blaney; Christoph Wirblich; Amy B Papaneri; Reed F Johnson; Carey J Myers; Terry L Juelich; Michael R Holbrook; Alexander N Freiberg; John G Bernbaum; Peter B Jahrling; Jason Paragas; Matthias J Schnell
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

2.  A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence.

Authors:  Amy B Papaneri; Christoph Wirblich; Jennifer A Cann; Kurt Cooper; Peter B Jahrling; Matthias J Schnell; Joseph E Blaney
Journal:  Virology       Date:  2012-08-11       Impact factor: 3.616

Review 3.  Ebola virus vaccines - reality or fiction?

Authors:  Chad E Mire; Thomas W Geisbert; Heinz Feldmann; Andrea Marzi
Journal:  Expert Rev Vaccines       Date:  2016-05-09       Impact factor: 5.217

4.  Immunogenicity studies in carnivores using a rabies virus construct with a site-directed deletion in the phosphoprotein.

Authors:  Ad Vos; Karl-Klaus Conzelmann; Stefan Finke; Thomas Müller; Jens Teifke; Anthony R Fooks; Andreas Neubert
Journal:  Adv Prev Med       Date:  2011-09-21

5.  Molecular epidemiology of rabies virus in Poland.

Authors:  Anna Orłowska; Jan Franciszek Żmudziński
Journal:  Arch Virol       Date:  2014-03-14       Impact factor: 2.574

6.  Evolutionary analysis of rabies virus isolates from Guangxi Province of southern China.

Authors:  Xian-Kai Wei; Xiao-Xia He; Yan Pan; Cheng Liu; Hai-Bo Tang; Yi-Zhi Zhong; Xiao-Ning Li; Jing-Jing Liang; Ting Rong Luo
Journal:  BMC Vet Res       Date:  2018-06-18       Impact factor: 2.741

7.  Environmental distribution of certain modified live-virus vaccines with a high safety profile presents a low-risk, high-reward to control zoonotic diseases.

Authors:  Jennifer R Head; Ad Vos; Jesse Blanton; Thomas Müller; Richard Chipman; Emily G Pieracci; Julie Cleaton; Ryan Wallace
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

8.  Responsiveness of various reservoir species to oral rabies vaccination correlates with differences in vaccine uptake of mucosa associated lymphoid tissues.

Authors:  Verena Te Kamp; Conrad M Freuling; Ad Vos; Peter Schuster; Christian Kaiser; Steffen Ortmann; Antje Kretzschmar; Sabine Nemitz; Elisa Eggerbauer; Reiner Ulrich; Jan Schinköthe; Tobias Nolden; Thomas Müller; Stefan Finke
Journal:  Sci Rep       Date:  2020-02-19       Impact factor: 4.379

9.  Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine.

Authors:  Joseph E Blaney; Andrea Marzi; Mallory Willet; Amy B Papaneri; Christoph Wirblich; Friederike Feldmann; Michael Holbrook; Peter Jahrling; Heinz Feldmann; Matthias J Schnell
Journal:  PLoS Pathog       Date:  2013-05-30       Impact factor: 6.823

10.  In Vivo Safety Studies With SPBN GASGAS in the Frame of Oral Vaccination of Foxes and Raccoon Dogs Against Rabies.

Authors:  Steffen Ortmann; Antje Kretzschmar; Christiane Kaiser; Thomas Lindner; Conrad Freuling; Christian Kaiser; Peter Schuster; Thomas Mueller; Ad Vos
Journal:  Front Vet Sci       Date:  2018-05-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.